Daxor Corp.

  • Market Cap: N/A
  • Industry: Capital Markets
  • ISIN: US2394671034
USD
12.85
-0.25 (-1.91%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Daxor Corp. stock-summary
stock-summary
Daxor Corp.
Capital Markets
Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The Company focuses on the development of the Blood Volume Analyzer (BVA) -100, an instrument that rapidly and accurately measures human blood volume. The Company’s instrument is used in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.The Company also owns the Daxor Oak Ridge Operations (DORO) facility in Oak Ridge, Tennessee. The semi-automated BVA provides blood volume measurements in human body for diagnosis and treatment in a range of medical and surgical conditions.
Company Coordinates stock-summary
Company Details
350 5th Ave Ste 4740 , NEW YORK NY : 10118-0002
stock-summary
Tel: 1 212 33085001 212 3308512
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 1 Schemes (1.01%)

Foreign Institutions

Held by 1 Foreign Institutions (0.06%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Michael Feldschuh
Chairman of the Board, President, Chief Executive Officer
Mr. Jonathan Feldschuh
Chief Scientific Officer, Director
Henry Cremisi
Director
Edward Feuer
Director
Joy Goudie
Independent Director
Mr James Lombard
Independent Director
Mr. Robert Willens
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2011)
Net Profit:
-1 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 55 Million ()

stock-summary
P/E

32.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.03

stock-summary
Return on Equity

3.68%

stock-summary
Price to Book

1.54